Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2026-04-11 @ 9:06 AM
Study NCT ID:
NCT01436968
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-30
First Post:
2011-09-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Sponsor:
Candel Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09
Start Date Type:
None
Primary Completion Date:
2024-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2030-12
Completion Date Type:
ESTIMATED
First Submit Date:
2011-09-19
First Submit QC Date:
None
Study First Post Date:
2011-09-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-07-11
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-07-28
Last Update Post Date:
2025-07-30
Last Update Post Date Type:
ACTUAL